Tazdait, M <br/><br/>
Patterns of responses in metastatic NSCLC during PD-1 or PDL-1 inhibitor therapy: Comparison of RECIST 1.1, irRECIST and iRECIST criteria.  [electronic resource] 

 -  European journal of cancer (Oxford, England : 1990)  01 2018 
 - 38-47 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1879-0852 
<br/><br/><label>Standard No.: </label>10.1016/j.ejca.2017.10.017  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--therapeutic use<br/>B7-H1 Antigen--antagonists & inhibitors<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Disease Progression<br/>Female<br/>Humans<br/>Kaplan-Meier Estimate<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Programmed Cell Death 1 Receptor--antagonists & inhibitors<br/>Response Evaluation Criteria in Solid Tumors<br/>Retrospective Studies